ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO723

Peritoneal Dialysis in Sichuan Province of China—Report from the Chinese National Renal Data System

Session Information

  • Peritoneal Dialysis - II
    November 04, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Dialysis

  • 608 Peritoneal Dialysis


  • Hong, Daqing, Sichuan Provincial People's Hospital, CHENGDU, China

The Chinese National Renal Data System (CNRDS) was established in 2010 to collect data from patients undergoing Peritoneal Dialysis in renal department of China. In this study, we aimed to study the patients of Sichuan province in the registry and analysis total characteristics and treatment effect and to examine whether or not the based clinical statistics effected the outcome of peritoneal dialysis, exploring the risk factors for peritoneal dialysis patients.


This study included 2654 patients undergoing peritoneal dialysis between January 2010 and December 2016. All data were conducted statistical analysis using SPSS 21.0.


Primary glomerular disease, secondary glomerular disease and hereditary nephritis were the first three causes (Figure 2). From 2010 to 2016, the number of patients was on the rise, while patients who died or dropped out were decreasing. All drugs including Erythropoietin, antihypertensive drugs, iron, calcium agents, phophorus lowering medicine and Vitamin D were beneficial for patients technical survival (P<0.01), in which the percentage of using erythropoietin,iron and antihypertensive agents were higher than other drugs. There was no significant association between based clinical variable and outcome of patients, except that ALB had a beneficial effect (P<0.05) for technical survival.


Our registry results, representing the first largest report of PD in the Southwest of China, indicate that peritoneal dialysis patients are increasing, which will require more and more medical cost to improve their outcome.

Figure 1 Prevalence of peritoneal dialysis patients.

Figure 2 Cause of end-stage renal disease of peritoneal dialysis patients